1 documents found
Information × Registration Number 0125U002129, R & D request Title A multi-center, randomized, double-blind, placebo-controlled, parallel-group Phase 3 study to investigate maintenance treatment with mirikizumab in patients with moderate to severe active ulcerative colitis Head Skrypnyk Ihor М., Доктор медичних наук Registration Date 11-04-2025 Organization Poltava State Medical University popup.description1 To study maintenance treatment with miricizumab in patients with moderate to severe active ulcerative colitis popup.nrat_date 2025-04-11 Close
search.res_rk
A multi-center, randomized, double-blind, placebo-controlled, parallel-group Phase 3 study to investigate maintenance treatment with mirikizumab in patients with moderate to severe active ulcerative colitis
Head: Skrypnyk Ihor М.. A multi-center, randomized, double-blind, placebo-controlled, parallel-group Phase 3 study to investigate maintenance treatment with mirikizumab in patients with moderate to severe active ulcerative colitis. Poltava State Medical University. № 0125U002129
1 documents found

Updated: 2026-03-21


Роздрукувати цю сторінку